Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: GreTai Sec M
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

TTY Biopharm Co Ltd

+ Add to Watchlist

4105:TT

69.10 TWD 0.40 0.58%

As of 02:31:58 ET on 05/05/2015.

Snapshot for TTY Biopharm Co Ltd (4105)

Open: 69.90 Day's Range: 68.80 - 70.00 Volume: 1,226,890
Previous Close: 69.50 52wk Range: 49.80 - 99.34 1-Yr Rtn: -24.64%

Stock Chart for 4105

No chart data available.
  • 4105:TT 69.10
  • 1D
  • 1M
  • 1Y
69.50
Interactive 4105 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 4105

Current P/E Ratio (ttm) 22.0126
Estimated P/E(12/2015) 24.7582
Relative P/E vs. TWOTCI 0.8519
Earnings Per Share (TWD) (ttm) 3.1391
Est. EPS (TWD) (12/2015) 2.7910
Est. PEG Ratio -
Market Cap (M TWD) 17,181.71
Shares Outstanding (M) 248.65
30 Day Average Volume 1,265,708
Price/Book (mrq) 4.0959
Price/Sale (ttm) 5.7659
Dividend Indicated Gross Yield 3.62%
Cash Dividend (TWD) 2.5000
Dividend Ex-Date
5 Year Dividend Growth 21.58%
Next Earnings Announcement 05/08/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 4105

  • Revenue
  • Net Income (M/TWD)
  • Profit Margin (%)

Company Profile & Key Executives for 4105

TTY Biopharm Co., Ltd. manufactures and markets various kinds of medicines. The company's products encompass a variety of therapeutic segments, including cardiology, gastroenterology, orthopedics and cancer.

Chang Wen-HuaVice ChairmanHsiao Ying-ChunExecutive Vice President
Huang Chun-YingExecutive Vice PresidentWu Hsueh-LiuVice President
More Company Profile & Key Executives for 4105

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil